Significant developments have impacted the application of immunoaffinity liquid chromatography-mass spectrometry (LC-MS) to regulated biotherapeutics. This presentation focuses on the latest LC-MS technologies and techniques that are impacting the development of protein-based drugs. Approaches taken are in line with industry trends and regulatory expectations established around bioanalysis.

What will you learn?

• The strengths and weaknesses of LC-MS for protein bioanalysis
• How to apply modern LC-MS technology, including nano-flow LC and high resolution mass spectrometry (HRMS)
• Principles around holistic bioanalytical strategies for biotherapeutics

Listen to the on-demand webinar featuring this presentation here.

Authors:
Stephen Lowes, Ph.D., Senior Scientific Director, Bioanalysis and ADME Services
Barry Jones, Ph.D., Associate Director, LCMS Biologics and Biomarkers